[Clinical study of cefotetan in complicated urinary tract infections].

Abstract

Clinical effectiveness and safety of Cefotetan were evaluated in 28 patients with complicated urinary tract infections. The results were excellent in 12 patients (42.9%), moderate in 10 patients (35.7%) and poor in 6 patients (21.6%), and the effectiveness rate was 78.6%. Bacteriologically, 24 (75%) out of 32 strains were eradicated. Subjective side effects, nausea and abdominal discomfort, were observed in one patient. Abnormal laboratory findings were observed in 6 patients, eosinophilia in 3 patients and slight elevation of transaminase in 3 patients.

• Authors: T Suzuki, H Soma, H Tazawa, W Hamada, K Sugihara, M Fukushi, H Eba
• Journal: Hinyokika kiyo. Acta urologica Japonica (Hinyokika Kiyo) Vol. 33 Issue 11 Pg. 1917-20 (Nov 1987) ISSN: 0018-1994 [Print] Japan
• PMID: 3481955 (Publication Type: English Abstract, Journal Article)

Chemical References

• Cephamycins
• Cefotetan
• Transaminases

Topics

• Adult
• Aged
• Aged, 80 and over
• Cefotetan
• Cephamycins (adverse effects, therapeutic use)
• Drug Evaluation
• Eosinophilia (chemically induced)
• Female
• Humans
• Male
• Middle Aged
• Transaminases (blood)
• Urinary Tract Infections (drug therapy, microbiology)